Showing posts with label Final. Show all posts
Showing posts with label Final. Show all posts

Friday, 21 March 2014

Final Exam: Laying Hands on a Death Row Inmate

Get customized medical news and FREE CME!Select Specialties and Topics of Interest to Customize Your NewsContinue to RegisterRegister for FREE customized news, conference, policy and practice coverage and CME tracking. Register Today

Earn Free CME Credits by reading the latest medical news in your specialty.

Sign Up
Published: Mar 20, 2014

On March 10, I found myself at the front gate of the Florida State Prison, stethoscope and blood pressure cuff in hand, to examine Robert Henry at the request of his public defender.

Henry is scheduled to be executed Thursday evening by lethal injection. His crime was the murder of two people during a robbery more than 30 years ago.

He's a 55-year-old African-American man with hypertension, elevated cholesterol, and a history of smoking. Florida will execute Henry with the drug midazolam, in combination with a paralyzing drug and potassium chloride. Midazolam is new for this purpose; it produces sedation, amnesia, and, in medically prescribed dosages, it lacks the ability to kill.

Florida will make deadly what is naturally not by using a dosage much larger than ever given by a physician. Scientifically, this reasoning is flawed as the drug works like a key in a lock. Once the lock is full, no additional drug increases effectiveness. Worse, midazolam is in short supply. The amount used to kill Henry could have treated 100 patients who now will have no access to midazolam.

Henry is likely plagued by coronary artery disease, common among men of his age, ethnicity, and health. Hypertension and coronary artery disease place Henry at risk of a heart attack from falling blood pressure as he is executed.

When the death warrant was signed for Henry, he was placed under constant surveillance. When he was moved within the prison, the entire prison was on lockdown. I was taken to a room within the prison where Henry was waiting.

How would I describe a professional relationship with Henry? He was not my patient. If he were, I owe him duties that I could not provide.

We chatted about his health, and he confessed the occurrence of atypical chest pain. In other circumstances I would change his medications, order tests to document coronary artery disease, advise on diet and exercise, all to enable a long life. No such follow-up would take place.

My examination also proved challenging. Privacy was ruled out immediately and he was shackled hand and foot, which proved to be a puzzling obstacle to obtaining his blood pressure. Shackled, he was unable to remove his shoes and socks. I assisted and replaced them on his feet after my exam, and tied his shoelaces. We discussed how he liked the laces tied and tucked so they would not catch and cause him to trip.

I documented a high suspicion of coronary artery disease. I thanked him for his time and was ushered away, out of the prison and outside under the cloudy Florida sky.

People wonder what is owed to Henry, a convicted double murderer, and why a doctor should treat him? Some say mercy is not owed to Mr. Henry, as long ago, he showed no mercy to those he killed. For me, a doctor's duty is to provide impartial care. If the patient is noble or terrible, my job does not change.

I believe murder is wrong and those who murder should be punished. But the Constitution of the United States prohibits cruel punishment, and I believe the use of midazolam to execute Mr. Henry will result in a needlessly cruel death. Doctors cannot make execution less cruel by advising on a better way to execute. I am not trained in execution. The medicalization of the death penalty has occurred by the State acting in place, but not in purpose, of physicians.

The use of midazolam, a drug in short supply, to kill when it should be used to heal, is unacceptable. As a final disturbing impersonation, execution by lethal injection occurs while laying on a gurney as opposed to "old sparky" and electrocution, which occurs while sitting.

The execution of Robert Henry will be cruel punishment, in spite of constitutional objection. When he is pronounced dead, a death certificate will be issued, and a cause of death must be stated. For all those executed in this country, that cause of death so listed is always "homicide."

Joel Zivot, MD, is assistant professor of anesthesiology and surgery at Emory University School of Medicine and the medical director of the cardiothoracic intensive care unit at Emory University Hospital Midtown.

Friday, 15 November 2013

HHS Releases Final Rule and Interim Final Rules on Affordable Care Act's State Health Insurance Exchanges

Duane Morris

On March 12, 2012, the U.S. Department of Health and Human Services (HHS) released the long-anticipated Final Rule and Interim Final Rules (the "Rules") on the Patient Protection and Affordable Care Act's (ACA) state health insurance exchanges ("Exchange(s)"), a key element of President Obama's healthcare reform plan. Set to go into effect on January 1, 2014, the goals of the Exchanges are to enhance competition, improve availability of affordable health insurance options and allow small businesses the same purchasing power that large businesses currently enjoy. As described in the Rules, the Exchanges will operate as competitive marketplaces, allowing individual consumers and small businesses to directly compare pricing and quality of health insurance options, among other factors.

The Final Rule incorporates two proposed rules originally published in mid-2011 that together implement what HHS refers to as the Exchange establishment and eligibility rules that address the eligibility, enrollment and plan function of the Exchanges. Affording substantial discretion to states in the design and operation of the Exchanges, the Final Rule details minimum federal standards for the establishment and operation of the Exchanges, minimum standards that health insurers must meet in order to participate in the Exchange and offer a qualified health plan, and standards of participation for the Small Business Health Options Program.

Additionally, several of the Rules are being published as Interim Final Rules, and HHS is requesting public comment relating to:

1.   The ability of a state to permit agents and brokers to assist qualified individuals in applying for advance payments of the premium tax credit and cost-sharing reductions for qualified health plans;
2.   Medicaid and CHIP regulations;
3.   Options for conducting eligibility determinations;
4.   Eligibility standards for cost-sharing reductions;
5.   Timeliness standards for Exchange eligibility determinations;
6.    Verification for applicants with special circumstances;
7.   Timeliness standards for the transmission of information for the administration of advance payments of the premium tax credit and cost-sharing reductions; and
8.   Agreements between agencies administering insurance affordability programs.

All public comments must be received by 5 p.m., 45 days from the date the Interim Final Rules are published in the Federal Register, which is currently set for March 27, 2012. The Final Rule will go into effect 60 days from that date. The full preliminary regulatory impact analysis of the Rules may be accessed at Preliminary Regulatory Impact Analysis.

HHS will be publishing separate rules on the ACA's provisions on certificates of exemption from the individual responsibility policy and payment; the definitions of essential health benefits, actuarial value and benefit design standards; and quality standards for the Exchanges and qualified health plans.

For Further Information

If you have any questions about this Alert, please contact Mitchell Goldman, Melissa S. Snyder, Elinor L. Hart, any member of the Health Law Practice Group or the attorney in the firm with whom you are regularly in contact.

Disclaimer: This Alert has been prepared and published for informational purposes only and is not offered, or should be construed, as legal advice. For more information, please see the firm's full disclaimer.

 © 1998-2011 Duane Morris LLP. Duane Morris is registered service mark of Duane Morris LLP.

Stethoscope and Medical Records

For more information about LexisNexis products and solutions connect with us through our corporate site.


View the original article here